514 related articles for article (PubMed ID: 34556813)
21. Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies.
Huang B; Zhang J; Zong W; Chen S; Zong Z; Zeng X; Zhang H
Front Immunol; 2023; 14():994698. PubMed ID: 36923402
[TBL] [Abstract][Full Text] [Related]
22. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
Front Immunol; 2020; 11():1402. PubMed ID: 32765498
[TBL] [Abstract][Full Text] [Related]
23. Immune involvement of the contralateral hemisphere in a glioblastoma mouse model.
Crommentuijn MHW; Schetters STT; Dusoswa SA; Kruijssen LJW; Garcia-Vallejo JJ; van Kooyk Y
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303613
[TBL] [Abstract][Full Text] [Related]
24. Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma.
Zhang H; Hong Y; Wu T; Ben E; Li S; Hu L; Xie T
Front Immunol; 2024; 15():1401967. PubMed ID: 38915399
[TBL] [Abstract][Full Text] [Related]
25. Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction.
Di Ianni N; Musio S; Pellegatta S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923299
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma.
Antonios JP; Soto H; Everson RG; Moughon D; Orpilla JR; Shin NP; Sedighim S; Treger J; Odesa S; Tucker A; Yong WH; Li G; Cloughesy TF; Liau LM; Prins RM
Neuro Oncol; 2017 Jun; 19(6):796-807. PubMed ID: 28115578
[TBL] [Abstract][Full Text] [Related]
27. Explicating the Pivotal Pathogenic, Diagnostic, and Therapeutic Biomarker Potentials of Myeloid-Derived Suppressor Cells in Glioblastoma.
Richard SA
Dis Markers; 2020; 2020():8844313. PubMed ID: 33204365
[TBL] [Abstract][Full Text] [Related]
28. Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression.
Nóbrega AHL; Pimentel RS; Prado AP; Garcia J; Frozza RL; Bernardi A
Curr Cancer Drug Targets; 2024; 24(6):579-594. PubMed ID: 38310461
[TBL] [Abstract][Full Text] [Related]
29. Microglia/macrophages express alternative proangiogenic factors depending on granulocyte content in human glioblastoma.
Blank A; Kremenetskaia I; Urbantat RM; Acker G; Turkowski K; Radke J; Schneider UC; Vajkoczy P; Brandenburg S
J Pathol; 2021 Feb; 253(2):160-173. PubMed ID: 33044746
[TBL] [Abstract][Full Text] [Related]
30. Macrophages/Microglia in the Glioblastoma Tumor Microenvironment.
Ma J; Chen CC; Li M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071306
[TBL] [Abstract][Full Text] [Related]
31. The Interplay between Glioblastoma and Its Microenvironment.
Dapash M; Hou D; Castro B; Lee-Chang C; Lesniak MS
Cells; 2021 Aug; 10(9):. PubMed ID: 34571905
[TBL] [Abstract][Full Text] [Related]
32. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128
[TBL] [Abstract][Full Text] [Related]
33. Macrophages and microglia: the cerberus of glioblastoma.
Buonfiglioli A; Hambardzumyan D
Acta Neuropathol Commun; 2021 Mar; 9(1):54. PubMed ID: 33766119
[TBL] [Abstract][Full Text] [Related]
34. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB
Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984
[TBL] [Abstract][Full Text] [Related]
35. Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth.
Achyut BR; Angara K; Jain M; Borin TF; Rashid MH; Iskander ASM; Ara R; Kolhe R; Howard S; Venugopal N; Rodriguez PC; Bradford JW; Arbab AS
Sci Rep; 2017 Oct; 7(1):13754. PubMed ID: 29062041
[TBL] [Abstract][Full Text] [Related]
36. Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment.
Khodadadi H; Salles ÉL; Alptekin A; Mehrabian D; Rutkowski M; Arbab AS; Yeudall WA; Yu JC; Morgan JC; Hess DC; Vaibhav K; Dhandapani KM; Baban B
Cannabis Cannabinoid Res; 2023 Oct; 8(5):824-834. PubMed ID: 34918964
[No Abstract] [Full Text] [Related]
37. The Dynamics of Interactions Among Immune and Glioblastoma Cells.
Eder K; Kalman B
Neuromolecular Med; 2015 Dec; 17(4):335-52. PubMed ID: 26224516
[TBL] [Abstract][Full Text] [Related]
38. Combination immunotherapy strategies for glioblastoma.
Chan HY; Choi J; Jackson C; Lim M
J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
[TBL] [Abstract][Full Text] [Related]
39. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells.
Hasan MN; Luo L; Ding D; Song S; Bhuiyan MIH; Liu R; Foley LM; Guan X; Kohanbash G; Hitchens TK; Castro MG; Zhang Z; Sun D
Theranostics; 2021; 11(3):1295-1309. PubMed ID: 33391535
[No Abstract] [Full Text] [Related]
40. Crosstalk Between Tumor-Associated Microglia/Macrophages and CD8-Positive T Cells Plays a Key Role in Glioblastoma.
Tu S; Lin X; Qiu J; Zhou J; Wang H; Hu S; Yao Y; Wang Y; Deng Y; Zhou Y; Shao A
Front Immunol; 2021; 12():650105. PubMed ID: 34394072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
